Evaluation of the Short Effects of a Rehabilitation Session on Gait Parameters in Patients With a Lesion of the Central Nervous System
Procedure Data
+ procedure Data
+ procedure Data
Collected from today forward - ProspectiveNervous System Diseases+4
+ Neurologic Manifestations
+ Signs and Symptoms
Cohort
Tracking disease incidence in order to identify risk factors and understand disease progression over time.Summary
Study start date: February 1, 2013
Actual date on which the first participant was enrolled.The aim of the study is to evaluate the short effects of a two rehabilitation session commonly performed in physical therapy, muscle strengthening of the lower limbs and effort reconditioning with cyclo ergometer, on gait characteristics (kinematics, kinetics and electromyographic) in patients with central nervous system lesion.
Protocol
This section provides details of the study plan, including how the study is designed and what the study is measuring.60 patients to be enrolled
Total number of participants that the clinical trial aims to recruit.Cohort
Eligibility
Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.Any sex
Biological sex of participants that are eligible to enroll.Over 18 Years
Range of ages for which participants are eligible to join.Healthy volunteers not allowed
If individuals who are healthy and do not have the condition being studied can participate.Conditions
Pathology
Criteria
Inclusion Criteria: Male or female adults aged ≥ 18 years receiving a motor rehabilitation in the service Hemiplegia after stroke or paraplegia incomplete ASIA C or D or multiple sclerosis (EPSS <5). Walking with or without technical assistance Patients who received and signed information and informed consent Patient who received physiotherapy session for rehabilitation of the lower limbs Patients able to perform the entire study Exclusion Criteria: Patient with safety measure Pregnant women, breastfeeding Patient who has received botulinum toxin injection of in the lower limbs between 3 weeks and 2 months prior to inclusion in the study Bilateral Brain damage, cerebellar syndrome, apraxia, severe aphasia Orthopedic complications preventing walking Patients who participated in a clinical study within 3 months prior to inclusion • No affiliation to a social security scheme (beneficiary or assignee)
Study Plan
Find out more about all the medication administered in this study, their detailed description and what they involve.3 intervention groups are designated in this study
This study does not include a placebo group
Treatment Groups
Study Objectives
Primary Objectives
Secondary Objectives
Study Centers
These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.This study has 1 location